Cenk Oguz

Haoma Medica Ltd is a UK based biotech company that focuses on treatments for Osteoporosis and Osteopenia as well as blood clotting management. The Osteoporosis & Osteopenia drug referred to as NaQuinate and commercially as Osteopura, is a novel class of compound, designed for low dose oral administration. Being a natural product, that preserves both bone mass and bone architecture, the safety profile of the therapeutic approach has significant potential for the long-term treatment of the serious problem of osteoporosis. The therapeutics in Osteopura are present in all people, but only in very, very small amounts, Osteopura boosts the levels of these agents to preserve bone integrity. Haoma Medica Limited started with the platform of “working with nature and not against it”. www.haomamedica.com